Merit Medical Sys (MMSI) Stock Price, Quote & News

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as verte...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 801 253 1600

Fax: 801 253 1652

Website: www.merit.com

Address:

1600 West Merit Parkway, South Jordan, United States

medguy Jan. 9 at 8:08 PM

Out with small gains $MMSI

0 · Reply

medguy Jan. 9 at 5:57 PM

Looking for a bounce $MMSI

0 · Reply

OfficialStocktwitsUser Jan. 2 at 12:43 PM

$MMSI RSI: 76.15, MACD: 0.7261 Vol: 1.78, MA20: 86.39, MA50: 86.01 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ESOPExpertV2 Dec. 25 at 10:59 AM

$MMSI The next leg of valuation movement will likely hinge on how management navigates competing priorities. Operating leverage needs to emerge without sacrificing balance‑sheet resilience. Any disconnect between guidance and results will be magnified by sentiment. This becomes a story about execution quality rather than promises made.

0 · Reply

ZacksResearch Dec. 23 at 7:45 PM

$MMSI down 9% YTD — is it poised for a comeback? 📈 Despite recent declines, Merit Medical's strong product portfolio and R&D investment drive optimism. The company saw 7.8% organic constant-currency growth in Q3'25, with cardiovascular momentum taking the lead. See if this Zacks Rank #3 stock is an opportunity 👉 https://www.zacks.com/stock/news/2808197/heres-why-you-should-retain-merit-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2808197-body-26102&ADID=SYND_STOCKTWITS_TWEET_2_2808197_BODY_26102

0 · Reply

ZacksResearch Dec. 23 at 6:45 PM

$MMSI is under pressure — but this isn’t a broken story 👀 Despite 2025 share pressure, the company is showing resilience with cardiovascular growth, margin expansion, and growing momentum from WRAPSODY CIE supporting the investment case. See why retaining this stock still makes sense right now 👉 https://www.zacks.com/stock/news/2808197/heres-why-you-should-retain-merit-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2808197-teaser-26101&ADID=SYND_STOCKTWITS_TWEET_2_2808197_TEASER_26101

0 · Reply

JarvisFlow Dec. 17 at 8:00 PM

Canaccord Genuity updates rating for Merit Medical Systems ( $MMSI ) to Buy, target set at 93 → 99.

0 · Reply

BillionerOfKing Dec. 9 at 4:00 PM

$MMSI Current Stock Price: $83.60 Contracts to trade: $85 MMSI Dec 19 2025 Call Entry: $0.35 Exit: $0.62 ROI: 77% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

BEATOFtheMARKET Nov. 17 at 10:48 AM

$MKSI $MLTX $MMSI $MNMD $MNST

0 · Reply

JarvisFlow Nov. 14 at 8:30 PM

Barrington Research updates rating for Merit Medical Systems ( $MMSI ) to Outperform, target set at 106.

0 · Reply

Merit Medical Systems, Inc. (MMSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 8, 2026, 4:05 PM EST - 5 days ago

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Nov 13, 2025, 1:50 AM EST - 2 months ago

Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update

BRBR LNTH MNDY PI POWL PRM RMBS

Nov 3, 2025, 9:25 AM EST - 2 months ago

Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Oct 30, 2025, 10:16 PM EDT - 2 months ago

Merit Medical Systems, Inc. (MMSI) Q3 2025 Earnings Call Transcript

Oct 15, 2025, 4:05 PM EDT - 3 months ago

PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

Oct 3, 2025, 9:25 AM EDT - 3 months ago

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

Oct 1, 2025, 9:25 AM EDT - 3 months ago

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology

Sep 12, 2025, 2:30 PM EDT - 4 months ago

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis

Sep 9, 2025, 12:18 AM EDT - 4 months ago

Merit Medical Has To Rebuild Some Confidence In The Growth Story

Aug 18, 2025, 9:25 AM EDT - 5 months ago

First Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America Registry

Aug 7, 2025, 9:25 AM EDT - 5 months ago

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

Jul 31, 2025, 11:43 AM EDT - 5 months ago

Merit Medical Systems, Inc. (MMSI) Q2 2025 Earnings Call Transcript

Jul 7, 2025, 4:05 PM EDT - 6 months ago

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

Jul 3, 2025, 4:05 PM EDT - 6 months ago

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

Jun 9, 2025, 12:46 PM EDT - 7 months ago

The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

CRM EXC MSI

May 20, 2025, 7:30 AM EDT - 8 months ago

Merit Medical Acquires Biolife Delaware, L.L.C.

May 6, 2025, 9:25 AM EDT - 9 months ago

Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis

May 5, 2025, 9:25 AM EDT - 9 months ago

Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial

Apr 25, 2025, 12:05 AM EDT - 9 months ago

Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript

Apr 9, 2025, 9:25 AM EDT - 9 months ago

Merit Medical Launches the Ventrax™ Delivery System

Apr 7, 2025, 5:10 PM EDT - 10 months ago

Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

Mar 27, 2025, 9:25 AM EDT - 10 months ago

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

Mar 25, 2025, 9:25 AM EDT - 10 months ago

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

Mar 18, 2025, 9:25 AM EDT - 10 months ago

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

Mar 16, 2025, 12:34 PM EDT - 10 months ago

Merit Medical: A Success Story That Keeps Getting Better

Mar 10, 2025, 9:25 AM EDT - 11 months ago

First Patient Enrolled in Merit Medical's PREEMIE Study

Feb 25, 2025, 10:39 PM EST - 11 months ago

Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 11 months ago

Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance

Jan 13, 2025, 7:10 PM EST - 1 year ago

Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025

Dec 20, 2024, 9:15 AM EST - 1 year ago

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

Dec 16, 2024, 4:00 PM EST - 1 year ago

Merit Medical Announces Resignation of President, Joseph Wright

Nov 25, 2024, 10:25 AM EST - 1 year ago

Fundus Camera Market Global Forecasts and Company Analysis 2025-2033, Profiles of Carl Zeiss Medites, Topcon Medical Systems, Merit Medical Systems, NIDEK, and Revenio Group

Nov 25, 2024, 9:15 AM EST - 1 year ago

Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients

Nov 1, 2024, 9:15 AM EDT - 1 year ago

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical

Oct 30, 2024, 11:52 PM EDT - 1 year ago

Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript

Oct 8, 2024, 5:43 PM EDT - 1 year ago

Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024

Sep 17, 2024, 7:00 AM EDT - 1 year ago

Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Merit Medical's WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients

Sep 11, 2024, 9:25 AM EDT - 1 year ago

Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress

Aug 3, 2024, 5:52 PM EDT - 1 year ago

Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:10 PM EDT - 1 year ago

Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance

Aug 1, 2024, 4:05 PM EDT - 1 year ago

Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings

Jul 1, 2024, 9:15 AM EDT - 1 year ago

Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®

Jun 18, 2024, 9:25 AM EDT - 1 year ago

Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024

Jun 15, 2024, 6:22 AM EDT - 1 year ago

Merit Medical: Undervalued With Multiple Growth Drivers In Play

Jun 14, 2024, 4:29 PM EDT - 1 year ago

Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says

May 21, 2024, 9:25 AM EDT - 1 year ago

Merit Medical Launches basixSKY™ Inflation Device

May 16, 2024, 4:05 PM EDT - 1 year ago

Merit Medical Shareholders Elect Silvia M. Perez as New Director

May 15, 2024, 4:05 PM EDT - 1 year ago

Merit Medical Executive Leadership Team Update

medguy Jan. 9 at 8:08 PM

Out with small gains $MMSI

0 · Reply

medguy Jan. 9 at 5:57 PM

Looking for a bounce $MMSI

0 · Reply

OfficialStocktwitsUser Jan. 2 at 12:43 PM

0 · Reply

ESOPExpertV2 Dec. 25 at 10:59 AM

0 · Reply

ZacksResearch Dec. 23 at 7:45 PM

0 · Reply

ZacksResearch Dec. 23 at 6:45 PM

0 · Reply

JarvisFlow Dec. 17 at 8:00 PM

Canaccord Genuity updates rating for Merit Medical Systems ( $MMSI ) to Buy, target set at 93 → 99.

0 · Reply

BillionerOfKing Dec. 9 at 4:00 PM

0 · Reply

BEATOFtheMARKET Nov. 17 at 10:48 AM

$MKSI $MLTX $MMSI $MNMD $MNST

0 · Reply

JarvisFlow Nov. 14 at 8:30 PM

Barrington Research updates rating for Merit Medical Systems ( $MMSI ) to Outperform, target set at 106.

0 · Reply

JarvisFlow Nov. 14 at 5:49 PM

Canaccord Genuity has updated their rating for Merit Medical Systems ( $MMSI ) to Buy with a price target of 93.

0 · Reply

JarvisFlow Nov. 14 at 3:13 PM

Wells Fargo has updated their rating for Merit Medical Systems ( $MMSI ) to Overweight with a price target of 95.

0 · Reply

OpenOutcrier Nov. 14 at 1:32 PM

$MMSI (-4.5% pre) Merit Medical withdraws reimbursement application, pivots strategy https://ooc.bz/l/84556

0 · Reply

SuperGreenToday Nov. 7 at 6:54 PM

$MMSI Share Price: $87.79 Contract Selected: Apr 17, 2026 $85 Calls Buy Zone: $6.80 – $8.40 Target Zone: $10.89 – $13.31 Potential Upside: 51% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

RunnerSignals Nov. 1 at 9:00 PM

$MEDP $CCJ $TEVA $TM $MMSI are heating up this week with breakouts and fresh volume spikes. see which charts traders are watching next https://stocksrunner.com/news/2025-11-01-top-momentum-stock-picks-on-the-rise

0 · Reply

ZacksResearch Oct. 31 at 6:12 PM

$MMSI beats Q3 estimates — bullish setup ahead? 🚀 👍 Adjusted EPS up 6.9%, topping estimates by 12.2% 📈 Revenue rose 13% on a reported basis, beating projections by 3.5% 🇺🇸 Strong growth in U.S. and international sales Discover why MMSI’s outlook is brightening 👉 https://www.zacks.com/stock/news/2782907/merit-medical-q3-earnings-revenues-beat-estimate-margins-expand?cid=sm-stocktwits-2-2782907-body-18845&ADID=SYND_STOCKTWITS_TWEET_2_2782907_BODY_18845

0 · Reply

ZacksResearch Oct. 31 at 5:12 PM

$MMSI crushes Q3 expectations 🔥 Strong revenue and expanding margins drove the beat, leading management to raise full-year guidance across multiple segments. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2782907/merit-medical-q3-earnings-revenues-beat-estimate-margins-expand?cid=sm-stocktwits-2-2782907-teaser-18824&ADID=SYND_STOCKTWITS_TWEET_2_2782907_TEASER_18824

0 · Reply

prismmarketview Oct. 16 at 1:28 PM

(NASDAQ: $MMSI) #MeritMedical announced a $22M deal to acquire the C2 CryoBalloon technology from Pentax of America, expanding its endoscopy portfolio. The minimally invasive GI device targets Barrett’s esophagus and GERD. https://prismmarketview.com/merit-medical-expands-gi-portfolio-with-22m-acquisition-of-c2-cryoballoon-technology/

0 · Reply

ZacksResearch Oct. 16 at 1:20 PM

$MMSI set to expand with C2 CryoBalloon acquisition — long-term growth play in GI market? 💡 📉 Stock down 16.8% YTD vs. industry’s 1.9% decline 💰 $22M deal opens doors to multibillion-dollar gastroenterology segment 📈 Revenue contributions expected to ramp up in 2026, despite near-term earnings pressure Discover the strategic move here 👉 https://www.zacks.com/stock/news/2769967/merit-medical-expands-gi-portfolio-with-22m-c2-cryoballoon-acquisition?cid=sm-stocktwits-2-2769967-body-16313&ADID=SYND_STOCKTWITS_TWEET_2_2769967_BODY_16313

0 · Reply

OpenOutcrier Oct. 16 at 12:45 PM

$MMSI (+1.9% pre) C2 CryoBalloon product line sold to Merit Medical; PENTAX Medical refocuses on flexible reusable endoscopy https://ooc.bz/l/80764

0 · Reply

ZacksResearch Oct. 16 at 12:21 PM

$MMSI just made a bold move into GI growth territory 👀 The $22M acquisition of C2 CryoBalloon from Pentax expands its gastroenterology lineup — a short-term hit, but a long-term play for stronger positioning in the GI market. See the full growth rationale here 👉 https://www.zacks.com/stock/news/2769967/merit-medical-expands-gi-portfolio-with-22m-c2-cryoballoon-acquisition?cid=sm-stocktwits-2-2769967-teaser-16312&ADID=SYND_STOCKTWITS_TWEET_2_2769967_TEASER_16312

0 · Reply

Market Cap	4.94B
Revenue (ttm)	1.36B
Net Income (ttm)	120.36M
EPS (ttm)	N/A
PE Ratio	25.18
Forward PE	24.20
Profit Margin	8.87%
Debt to Equity Ratio	0.48

Volume	849,400
Avg Vol	705,186
Day's Range	N/A - N/A
Shares Out	59.29M
Stochastic %K	1%
Beta	0.62
Analysts	Strong Sell
Price Target	$104.30